2m 2m 2m 2m 2m 2m 2m
Puma Biotech (PBYI)
NASDAQ
$8.37+$0.29 (+3.59%)
Price as of Jul 14, 2026 11:43 AM EDT- $411.3MMarket Cap
- 134.20%1-Year Change
- BiotechnologyIndustry
Puma Biotech (PBYI)
$8.37+$0.29 (+3.59%)
PBYI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.08 | ||
Change | +$0.08 (+1.00%) | ||
Open | $7.95 | ||
High | $8.18 | ||
Low | $7.72 | ||
Previous Close | $8.00 | ||
Volume | 293,397 | ||
30-Day Average Volume | 395,080 | ||
1-Week Change | -1.70% | ||
1-Month Change | 10.23% | ||
1-Year Change | 134.20% | ||
3-Year Change | 132.18% | ||
5-Year Change | -2.88% | ||
Fundamentals | |||
Shares Outstanding | 50.9M | ||
Total Assets | $192.7M | ||
Market Cap | $411.3M | ||
Enterprise Value | $386.4M | ||
Period: QTR TTM FY | |||
Revenue | $42.0M | ||
Net Income | -$3.8M | ||
Free Cash Flow | $15.4M | ||
EBIT | -$3.4M | ||
EBITDA | -$843,000.00 | ||
Net Working Capital | $82.5M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -458 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 3 | ||
P/E | -115 | ||
PEG | 1 | ||
Price/Free Cash Flow | 27 | ||
Price/Operating Cash Flow | 27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue